Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DeCIDE: Docetaxel-based induction in head and neck cancer
NCT00117572Phase 3Completed
- Sponsor
- University of Chicago
- Start
- Nov 2004
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of docetaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Chicago. Started Nov 2004; status: completed.
02
Drugs
docetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00117572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117572.